Challenges in treating liver fibrosis

by Jorge L. Poo, M.D., Linda E. Muñoz
Published 2014-11-01

Efficacy of triple therapy with thymalfasin, peginterferon α-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders

by Jorge L. Poo, Francisco Sánchez Ávila, David Kershenobich, Xochitl García Samper, Rocío Torres-Ibarra, Julieta Góngora, Carlos Cano, Miguel Parada, Misael Uribe
Published 2008-10-01

Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial

by Jonathan S. Chávez-Iñiguez, Jorge L. Poo, Miguel Ibarra-Estrada, Leonel García-Benavides, Guillermo Navarro-Blackaller, Cynthia Cervantes-Sánchez, Eduardo Nungaray-Pacheco, Ramón Medina-González, Juan Armendariz-Borunda, Guillermo García-García
Published 2021-01-01

Etiology of Liver Cirrhosis in Mexico

by Nahum Méndez-Sánchez, PhD, MD, MD Juan R. Aguilar-Ramírez, PhD, MD, Angel Reyes, MD, Margarita Dehesa, MD, Alberto Juárez, MD, Beatriz Castañeda, MD, Francisco Sánchez-Avila, MD, Jorge L. Poo, MD, Luis Guevara González, MD, Javier Lizardi, MD, Miguel A. Valdovinos, MD, Misael Uribe, MD, Ana M. Contreras, MD, Patricia Tirado, MD, Jesús Aguirre, MD, Cesar Rivera-Benítez, MD, Ramón Santiago-Santiago, MD, Francisco Bosques-Padilla, MD, Linda Muñoz, PhD, MD, Arnoldo Guerrero, MD, Mayra Ramos, MD, Heriberto Rodríguez-Hernández, MD, Jannett Jacobo-Karam, MD
Published 2004-01-01